BioPlus Acquisition (BioPlus Acquisition) Interest Expense : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioPlus Acquisition's interest expense for the three months ended in Jun. 2023 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioPlus Acquisition's Operating Income for the three months ended in Jun. 2023 was $ -1.28 Mil. BioPlus Acquisition's Interest Expense for the three months ended in Jun. 2023 was $ 0.00 Mil. GuruFocus does not calculate BioPlus Acquisition's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioPlus Acquisition Interest Expense Historical Data

The historical data trend for BioPlus Acquisition's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Interest Expense Chart

BioPlus Acquisition Annual Data

Trend

Dec21

Dec22

Interest Expense

BioPlus Acquisition Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Interest Expense	Get a 7-Day Free Trial					-	-	-	-	-

BioPlus Acquisition Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

BioPlus Acquisition (NAS:BIOSW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioPlus Acquisition's Interest Expense for the three months ended in Jun. 2023 was $0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was $-1.28 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was $5.00 Mil.

BioPlus Acquisition's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

GuruFocus does not calculate BioPlus Acquisition's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.